Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

NCT04229264 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DRUG: Apixaban
DRUG: ASA
DRUG: Clopidogrel 75mg

Sponsor

Science Valley Research Institute

Collaborators

[object Object]